Evidence map›Paper›PMID 17888982›Full record

ArticleThe Annals of thoracic surgery2007

Cardioplegia and diazoxide modulate STAT3 activation and DNA binding.

Yng-Ju Hsieh, Hidetaka Wakiyama, Sidney Levitsky, James D McCully

Open access · bronzeAbstract read
In one paragraph

Article in The Annals of thoracic surgery, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yng-Ju HsiehDivision of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts 02115, USA.
Hidetaka Wakiyama
Sidney Levitsky
James D McCully
Beth Israel Deaconess Medical Center · US

Funding

MYOCARDIAL PROTECTION: REPERFUSION INJURY AMELIORATIONR01HL029077 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LEVITSKY, SIDNEY, MCCULLY, JAMES D · 1985 to 2010
$4.1M
NHLBI NIH HHS R01 HL029077
6 · The paper itself

Abstract

backgroundPreviously, we have shown that magnesium supplemented potassium (DSA) cardioplegia and DSA containing diazoxide (DSA+DZX) significantly decrease apoptosis after ischemia. The mechanism for this enhanced cardioprotection was unknown, but we believed that alterations in signal transducers and activators of transcription (STATs) may play a role. To investigate this hypothesis, we examined the effects of DSA and DSA+DZX cardioplegia on STAT1/3 phosphorylation and DNA binding in the in situ blood perfused pig heart model.

methodsPigs (32 to 42 kg) undergoing total cardiopulmonary bypass underwent left anterior descending coronary artery occlusion for 30 minutes. The aorta was crossclamped and DSA (n = 6) or DSA+DZX (n = 6) cardioplegia was administered, followed by 30 minutes of global ischemia and 120 minutes of reperfusion. Control hearts (n = 3) received cardiopulmonary bypass and sham reperfusion only. Tissue samples from regional and global ischemia zones were harvested and used for Western blot and electrophoretic mobility shift assay.

resultsRegional and global ischemia significantly increase proapoptotic STAT1 tyrosine phosphorylation. This increase is significantly greater in the regional as compared with the global ischemia zone. Tyrosine phosphorylation of antiapoptotic STAT3 is increased in the global ischemic zone but is significantly decreased in the regional ischemic zone and is associated with increased apoptosis. The DSA+DZX significantly increases tyrosine phosphorylation of antiapoptotic STAT3 and DNA binding in the regional ischemia zone and significantly decreases apoptosis.

conclusionsThe addition of diazoxide to DSA cardioplegia significantly decreases apoptosis by significantly increasing tyrosine phosphorylation of STAT3 and its DNA binding and represents an additional modality for enhancing myocardial protection.

Indexed as

Heart Arrest, InducedAnimalsApoptosisBinding SitesBlotting, WesternCardioplegic SolutionsDiazoxideDisease Models, AnimalDNAElectrophoresisFemaleIschemic Preconditioning, MyocardialMaleMitochondria, HeartMyocardial Reperfusion InjuryPhosphorylationCardioplegic SolutionsDiazoxideDNASTAT3 Transcription FactorTyrosine

Identifiers

PMID17888982
PMCPMC3671580
OpenAlexW2071556771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.